Atrium Mortgage Investment Corporation
AMIVF
$7.29
-$0.0876-1.19%
| Weiss Ratings | AMIVF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | C+ | |||
| Rating Factors | AMIVF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Excellent | |||
| Growth Index | Fair | |||
| Efficiency Index | Good | |||
| Solvency Index | Excellent | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | AMIVF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -0.11 | |||
| Price History | AMIVF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -2.70% | |||
| 30-Day Total Return | -4.84% | |||
| 60-Day Total Return | -8.95% | |||
| 90-Day Total Return | -11.90% | |||
| Year to Date Total Return | -4.39% | |||
| 1-Year Total Return | -13.68% | |||
| 2-Year Total Return | -23.96% | |||
| 3-Year Total Return | -46.11% | |||
| 5-Year Total Return | -45.59% | |||
| 52-Week High % Change | -17.48% | |||
| 52-Week Low % Change | 2.10% | |||
| Price | AMIVF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $8.83 | |||
| 52-Week Low Price | $7.14 | |||
| 52-Week Low Price (Date) | Feb 03, 2025 | |||
| 52-Week High Price (Date) | Sep 17, 2024 | |||
| Valuation | AMIVF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 345.12M | |||
| Enterprise Value | -- | |||
| Price/Earnings (TTM) | 9.42 | |||
| Earnings Per Share (TTM) | 0.77 | |||
| Earnings Per Share Growth | -11.03% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 9.15 | |||
| Price/Book (Q) | 0.89 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $7.29 | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | -- | |||
| Market Cap Category | Small Cap | |||
| Dividends and Shares | AMIVF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 53.09M | |||
| Dividend Yield | 8.95% | |||
| Div. Per Share (Most Recent) | $0.05 | |||
| Dividend Per Share (TTM) | $0.65 | |||
| Payout Ratio (TTM) | 78.78% | |||
| Dividend Per Share (Most Recent) | $0.05 | |||
| Company Info | AMIVF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 416 867 1053 | |||
| Address | 20 Adelaide Street East Toronto, ON M5C 2T6 | |||
| Website | atriummic.com | |||
| Country | Canada | |||
| Year Founded | 2001 | |||
| Profitability | AMIVF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 81.82% | |||
| Profit Margin | 81.70% | |||
| Management Effectiveness | AMIVF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -- | |||
| Return on Equity | 9.49% | |||
| Income Statement | AMIVF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 26.40K | |||
| Total Revenue (TTM) | 42.32M | |||
| Revenue Per Share | $0.80 | |||
| Gross Profit (TTM) | 35.98M | |||
| EBITDA (TTM) | -- | |||
| EBIT (TTM) | -- | |||
| Net Income (TTM) | 34.58M | |||
| Net Income Avl. to Common (TTM) | 34.58M | |||
| Total Revenue Growth (Q YOY) | 4.10% | |||
| Earnings Growth (Q YOY) | 3.83% | |||
| EPS Diluted (TTM) | 0.77 | |||
| EPS Diluted Growth (Q YOY) | 1.82% | |||
| Balance Sheet | AMIVF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | -- | |||
| Cash Per Share (Q) | -- | |||
| Total Current Assets (Q) | 668.02M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 365.38M | |||
| Current Ratio (Q) | 71.296 | |||
| Book Value Per Share (Q) | $8.21 | |||
| Total Assets (Q) | 668.83M | |||
| Total Current Liabilities (Q) | 9.37M | |||
| Total Debt (Q) | 297.36M | |||
| Total Liabilities (Q) | 303.45M | |||
| Total Common Equity (Q) | 365.38M | |||
| Cash Flow | AMIVF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -31.83M | |||
| Cash from Financing (TTM) | -29.76M | |||
| Net Change in Cash (TTM) | -- | |||
| Levered Free Cash Flow (TTM) | -- | |||
| Cash from Operations (TTM) | 61.58M | |||
